Therapeutic strategies in pneumonia: going beyond antibiotics

Holger Müller-Redetzky1, Jasmin Lienau1, Norbert Suttorp1

  • 1Dept of Infectious Diseases and Pulmonary Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Insights

Severe pneumonia causes lung injury via immune dysregulation. While preclinical studies show promise, effective treatments beyond antibiotics for pneumonia-induced lung failure, sepsis, and acute respiratory distress syndrome are still needed.

Area of Science:

  • Immunology
  • Pulmonology
  • Critical Care Medicine

Background:

  • Innate immune system dysregulation contributes to lung injury in severe pneumonia.
  • Breakdown of vascular barrier function, hyperinflammation, and microcirculatory failure worsen patient outcomes.
  • Current treatments for pneumonia-induced lung failure, sepsis, and ARDS are limited.

Purpose of the Study:

  • To review adjuvant therapeutic strategies for pneumonia and its complications.
  • To discuss future perspectives in treating lung failure associated with pneumonia.

Main Methods:

  • Mini-review of preclinical and experimental studies.
  • Focus on adjuvant therapies beyond antibiotics.
  • Discussion of sepsis and acute respiratory distress syndrome (ARDS) as complications.

Main Results:

  • Numerous therapeutic targets and approaches show promise in preclinical models.
  • No specific preventive or curative strategies currently exist for pneumonia-induced lung failure.
  • Adjuvant therapies are being explored for pneumonia, sepsis, and ARDS.

Conclusions:

  • Targeting innate immune dysregulation is crucial for treating severe pneumonia.
  • Further research is needed to translate preclinical findings into clinical practice.
  • Adjuvant therapies hold potential for improving outcomes in pneumonia and its severe complications.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
47
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
647
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.2K